|
1
|
Kivisaari A and Kähäri VM: Squamous cell
carcinoma of the skin: Emerging need for novel biomarkers. World J
Clin Oncol. 4:85–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Y, Huang C and Yang X: Characterization
of TCF4-mediated oncogenic role in cutaneous squamous cell
carcinoma. Int J Clin Exp Pathol. 12:3583–3594. 2019.PubMed/NCBI
|
|
3
|
Zhang L, Qin H, Wu Z, Chen W and Zhang G:
Pathogenic genes related to the progression of actinic keratoses to
cutaneous squamous cell carcinoma. Int J Dermatol. 57:1208–1217.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Niu T, Tian Y, Wang G, Guo G, Tong Y and
Shi Y: Inhibition of ROS-NF-κB-dependent autophagy enhances
Hypocrellin A united LED red light-induced apoptosis in squamous
carcinoma A431 cells. Cell Signal. 69:1095502020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burton KA, Ashack KA and Khachemoune A:
Cutaneous squamous cell carcinoma: A review of high-risk and
metastatic disease. Am J Clin Dermatol. 17:491–508. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Q, Huang D, Zhang Z, Feng Y, Fu M,
Wei M, Zhou J, Huang Y, Liu S and Shi R: High expression of TMEM40
contributes to progressive features of tongue squamous cell
carcinoma. Oncol Rep. 41:154–164. 2019.PubMed/NCBI
|
|
7
|
Yue Y, Grossmann B, Ferguson-Smith M, Yang
F and Haaf T: Comparative cytogenetics of human chromosome 3q21.3
reveals a hot spot for ectopic recombination in hominoid evolution.
Genomics. 85:36–47. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yue Y, Grossmann B, Tsend-Ayush E,
Grutzner F, Ferguson-Smith MA, Yang F and Haaf T: Genomic structure
and paralogous regions of the inversion breakpoint occurring
between human chromosome 3p12.3 and orangutan chromosome 2.
Cytogenet Genome Res. 108:98–105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Müller S, Stanyon R, Finelli P,
Archidiacono N and Wienberg J: Molecular cytogenetic dissection of
human chromosomes 3 and 21 evolution. Proc Natl Acad Sci USA.
97:206–211. 2000. View Article : Google Scholar
|
|
10
|
Zhang QY, Fu MT, Zhang ZF, Feng YZ, Wei M,
Zhou JY and Shi R: Expression of TMEM40 in bladder cancer and its
correlation with clinicopathological parameters. Int J Clin Exp
Pathol. 10:8050–8057. 2017.PubMed/NCBI
|
|
11
|
Darai E, Kost-Alimova M, Kiss H, Kansoul
H, Klein G and Imreh S: Evolutionarily plastic regions at human
3p21.3 coincide with tumor breakpoints identified by the
‘elimination test’. Genomics. 86:1–12. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu X, Teng H, Marques A, Ashgari F and
Ibrahim SM: High resolution mapping of Cia3: A common arthritis
quantitative trait loci in different species. J Immunol.
182:3016–3023. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang ZF, Zhang HR, Zhang QY, Lai SY, Feng
YZ, Zhou Y, Zheng SR, Shi R and Zhou JY: High expression of TMEM40
is associated with the malignant behavior and tumorigenesis in
bladder cancer. J Transl Med. 16:92018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Farshchian M, Nissinen L, Siljamäki E,
Riihilä P, Piipponen M, Kivisaari A, Kallajoki M, Grénman R,
Peltonen J, Peltonen S, et al: Tumor cell-specific AIM2 regulates
growth and invasion of cutaneous squamous cell carcinoma.
Oncotarget. 8:45825–45836. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bottomley MJ, Thomson J, Harwood C and
Leigh I: The role of the immune system in cutaneous squamous cell
carcinoma. Int J Mol Sci. 20:20092019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin N, Zhou Y, Lian X and Tu Y:
MicroRNA-31 functions as an oncogenic microRNA in cutaneous
squamous cell carcinoma cells by targeting RhoTBT1. Oncol Lett.
13:1078–1082. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stratigos A, Garbe C, Lebbe C, Malvehy J,
del Marmol V, Pehamberger H, Peris K, Becker JC, Zalaudek I, Saiag
P, et al: Diagnosis and treatment of invasive squamous cell
carcinoma of the skin: European consensus-based interdisciplinary
guideline. Eur J Cancer. 51:1989–2007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Farshchian M, Nissinen L, Siljamäki E,
Riihilä P, Toriseva M, Kivisaari A, Ala-Aho R, Kallajoki M,
Veräjänkorva E, Honkanen HK, et al: EphB2 promotes progression of
cutaneous squamous cell carcinoma. J Invest Dermatol.
135:1882–1892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
Relative Gene Expression Data Using Real-Time Quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou M, Liu W, Ma S, Cao H, Peng X, Guo L,
Zhou X, Zheng L, Guo L, Wan M, et al: A novel onco-miR-365 induces
cutaneous squamous cell carcinoma. Carcinogenesis. 34:1653–1659.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McGuire JF, Ge NN and Dyson S: Nonmelanoma
skin cancer of the head and neck I: Histopathology and clinical
behavior. Am J Otolaryngol. 30:121–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martinez JC and Cook JL: High-risk
cutaneous squamous cell carcinoma without palpable lymphadenopathy:
Is there a therapeutic role for elective neck dissection? Dermatol
Surg. 33:410–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weinberg AS, Ogle CA and Shim EK:
Metastatic cutaneous squamous cell carcinoma: An update. Dermatol
Surg. 33:885–899. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Zhou C, Zhang C, Xie X, Zhou Z, Zhou
M, Chen L and Ding Z: MicroRNA-664 functions as an oncogene in
cutaneous squamous cell carcinomas (cSCC) via suppressing
interferon regulatory factor 2. J Dermatol Sci. 94:330–338. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Trakatelli M, Ulrich C, Del MV, Euvrard S,
Stockfleth E and Abeni D: Epidemiology of nonmelanoma skin cancer
(NMSC) in Europe: Accurate and comparable data are needed for
effective public health monitoring and interventions. Br J
Dermatol. 156 (Suppl 3):S1–S7. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alam M and Ratner D: Cutaneous
squamous-cell carcinoma. N Engl J Med. 344:975–983. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng C, Zhang HL, Zeng A, Bai M and Wang
XJ: Tumor-suppressive microRNA-216b binds to TPX2, activating the
p53 signaling in human cutaneous squamous cell carcinoma. Mol Ther
Nucleic Acids. 20:186–195. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tian K, Liu W, Zhang J, Fan X, Liu J, Zhao
N, Yao C and Miao G: MicroRNA-125b exerts antitumor functions in
cutaneous squamous cell carcinoma by targeting the STAT3 pathway.
Cell Mol Biol Lett. 25:122020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dlugosz A, Merlino G and Yuspa SH:
Progress in cutaneous cancer research. J Investig Dermatol Symp
Proc. 7:17–26. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mavropoulos JC, Aldabagh B and Arron ST:
Prospects for personalized targeted therapies for cutaneous
squamous cell carcinoma. Semin Cutan Med Surg. 33:72–75. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu D, Zhou G, Shi H, Chen B, Sun X and
Zhang X: Downregulation of transmembrane protein 40 by miR-138-5p
suppresses cell proliferation and mobility in clear cell renal cell
carcinoma. Iran J Biotechnol. 18:e22702020.PubMed/NCBI
|
|
32
|
Ala-aho R, Ahonen M, George SJ, Heikkilä
J, Grénman R, Kallajoki M and Kähäri VM: Targeted inhibition of
human collagenase-3 (MMP-13) expression inhibits squamous cell
carcinoma growth in vivo. Oncogene. 23:5111–5123. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johansson N, Airola K, Grénman R,
Kariniemi AL, Saarialho-Kere U and Kähäri VM: Expression of
collagenase-3 (matrix metalloproteinase-13) in squamous cell
carcinomas of the head and neck. Am J Pathol. 151:499–508.
1997.PubMed/NCBI
|
|
34
|
Le XF, Bedrosian I, Mao W, Murray M, Lu Z,
Keyomarsi K, Lee MH, Zhao J and Bast RC Jr: Anti-HER2 antibody
trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression
via the PI3K pathway. Cell Cycle. 5:1654–1661. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li X, Ding R, Han Z, Ma Z and Wang Y:
Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide
inhibits proliferation, migration and invasion in oral squamous
cell carcinoma cells. Biomed Pharmacother. 96:434–442. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang XQ, Feng H, Li ZY, Guo J and Li M:
Aspirin is involved in the cell cycle arrest, apoptosis, cell
migration, and invasion of oral squamous cell carcinoma. Int J Mol
Sci. 19:20292018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Santamaría D, Barrière C, Cerqueira A,
Hunt S, Tardy C, Newton K, Cáceres JF, Dubus P, Malumbres M and
Barbacid M: Cdk1 is sufficient to drive the mammalian cell cycle.
Nature. 448:811–815. 2007. View Article : Google Scholar
|
